Home » Inceptor Bio doses first subject in trial of IB-T101 for renal cell carcinoma

Inceptor Bio doses first subject in trial of IB-T101 for renal cell carcinoma

by gullapalli | Feb 26, 2025 | Articles | 0 Comments